These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21810072)

  • 41. The experience of native peer facilitators in the campaign against type 2 diabetes.
    Struthers R; Hodge FS; De Cora L; Geishirt-Cantrell B
    J Rural Health; 2003; 19(2):174-80. PubMed ID: 12696854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of abuse-deterrent formulation of OxyContin.
    Cicero TJ; Ellis MS; Surratt HL
    N Engl J Med; 2012 Jul; 367(2):187-9. PubMed ID: 22784140
    [No Abstract]   [Full Text] [Related]  

  • 43. Impacts of alcohol availability on Tribal lands where alcohol is prohibited: A community-partnered qualitative investigation.
    Lee JP; Pagano A; Moore RS; Tilsen N; Henderson JA; Iron Shell A; Davids S; LeBeaux L; Gruenewald P
    Int J Drug Policy; 2018 Apr; 54():77-86. PubMed ID: 29414489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Providing Culturally Appropriate Education on Type 2 Diabetes to Rural American Indians: Emotions and Racial Consciousness.
    Struthers R; Kaas M; Hill DL; Hodge F; DeCora L; Geishirt-Cantrell B
    J Rural Community Psychol; 2003; E6(1):. PubMed ID: 25383395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of Pain Management among American Indian Cancer Survivors.
    Hodge F; Nandy K; Cadogan M; Itty T; Warda U; Martinez F; Quan A
    J Health Care Poor Underserved; 2016; 27(2):636-43. PubMed ID: 27180700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Introducing healing circles and talking circles into primary care.
    Mehl-Madrona L; Mainguy B
    Perm J; 2014; 18(2):4-9. PubMed ID: 24867544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of OxyContin by adolescent students.
    Adlaf EM; Paglia-Boak A; Brands B
    CMAJ; 2006 Apr; 174(9):1303. PubMed ID: 16636332
    [No Abstract]   [Full Text] [Related]  

  • 48. Adolescent OxyContin Abuse.
    Katz DA; Hays LR
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):231-4. PubMed ID: 14726731
    [No Abstract]   [Full Text] [Related]  

  • 49. Curious Mode of Curing Diseases, Practised by a Tribe of North-American Indians.
    Med Phys J; 1814 Mar; 31(181):209-210. PubMed ID: 30493507
    [No Abstract]   [Full Text] [Related]  

  • 50. OxyContin maker stops marketing opioids, as report details payments to advocacy groups.
    Dyer O
    BMJ; 2018 Feb; 360():k791. PubMed ID: 29459379
    [No Abstract]   [Full Text] [Related]  

  • 51. Sixty seconds on . . . OxyContin.
    Gulland A
    BMJ; 2018 Feb; 360():k914. PubMed ID: 29487064
    [No Abstract]   [Full Text] [Related]  

  • 52. Family behind OxyContin named in lawsuit for the first time.
    Dyer O
    BMJ; 2018 Jun; 361():k2660. PubMed ID: 29907626
    [No Abstract]   [Full Text] [Related]  

  • 53. OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form.
    Fudin J; Raouf M; Wegrzyn EL
    J Pain Res; 2016; 9():609-12. PubMed ID: 27660487
    [No Abstract]   [Full Text] [Related]  

  • 54. A realist review of best practices and contextual factors enhancing treatment of opioid dependence in Indigenous contexts.
    Henderson R; McInnes A; Danyluk A; Wadsworth I; Healy B; Crowshoe L
    Harm Reduct J; 2023 Mar; 20(1):34. PubMed ID: 36932417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding opioid use within a Southwestern American Indian Reservation Community: A qualitative study.
    Waugh E; Ivanich J; O'Keefe V; Usher J; Haroz E; Goklish N; Kastler G; Nestadt P; Cwik M
    J Rural Health; 2023 Jan; 39(1):179-185. PubMed ID: 35347759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk and protective factors for opioid misuse in American Indian adolescents.
    Nalven T; Spillane NS; Schick MR
    Drug Alcohol Depend; 2020 Jan; 206():107736. PubMed ID: 31765857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives.
    Venner KL; Donovan DM; Campbell ANC; Wendt DC; Rieckmann T; Radin SM; Momper SL; Rosa CL
    Addict Behav; 2018 Nov; 86():111-117. PubMed ID: 29914717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse.
    Cicero TJ; Ellis MS
    Dialogues Clin Neurosci; 2017 Sep; 19(3):259-269. PubMed ID: 29302223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychosocial risks of prescription drug misuse among U.S. racial/ethnic minorities: A systematic review.
    Peteet BJ
    J Ethn Subst Abuse; 2019; 18(3):476-508. PubMed ID: 29173117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Misuse of Prescription Opioid Medication among Women: A Scoping Review.
    Hemsing N; Greaves L; Poole N; Schmidt R
    Pain Res Manag; 2016; 2016():1754195. PubMed ID: 27445597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.